SIVA1 (SIVA1, Apoptosis-Inducing Factor) (2014)
- Autores:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.4267/2042/53646
- Assuntos: GENÉTICA MOLECULAR; APOPTOSE
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Atlas of genetics and Cytogenetics in Oncology and Haematology
- ISSN: 1768-3262
- Volume/Número/Paginação/Ano: v. 18, n. 5, p. 334-339, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MACHADO NETO, João Agostinho e TRAINA, Fabiola. SIVA1 (SIVA1, Apoptosis-Inducing Factor). Atlas of genetics and Cytogenetics in Oncology and Haematology, v. 18, n. 5, p. 334-339, 2014Tradução . . Disponível em: https://doi.org/10.4267/2042/53646. Acesso em: 24 abr. 2024. -
APA
Machado Neto, J. A., & Traina, F. (2014). SIVA1 (SIVA1, Apoptosis-Inducing Factor). Atlas of genetics and Cytogenetics in Oncology and Haematology, 18( 5), 334-339. doi:10.4267/2042/53646 -
NLM
Machado Neto JA, Traina F. SIVA1 (SIVA1, Apoptosis-Inducing Factor) [Internet]. Atlas of genetics and Cytogenetics in Oncology and Haematology. 2014 ; 18( 5): 334-339.[citado 2024 abr. 24 ] Available from: https://doi.org/10.4267/2042/53646 -
Vancouver
Machado Neto JA, Traina F. SIVA1 (SIVA1, Apoptosis-Inducing Factor) [Internet]. Atlas of genetics and Cytogenetics in Oncology and Haematology. 2014 ; 18( 5): 334-339.[citado 2024 abr. 24 ] Available from: https://doi.org/10.4267/2042/53646 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
Informações sobre o DOI: 10.4267/2042/53646 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas